Articles

Ex-Lilly partner wins latest suit over Actos’ cancer risk

Takeda Pharmaceutical was found not liable for the bladder cancer of two women who used its Actos diabetes medication in the company’s latest trial over the drug. Actos was marketed for Takeda in the United States by Eli Lilly and Co. from July 1999 to March 2006.

Read More

Republic Airways considers ending $3B jet order

The 40 Bombardier CS300 aircraft on order at Republic Airways Holdings Inc. are no longer a top priority as the Indianapolis-based company returns to its roots as a provider of regional flights for larger carriers, CEO Bryan Bedford said.

Read More

UPDATE: Toyota to quit Camry production in Lafayette

Fuji Heavy Industries Ltd., the maker of Subaru cars, will stop making Camry cars in the U.S. for its largest shareholder, Toyota Motor Corp., in the second half of 2016. About 100,000 Camrys are made annually at the Indiana plant.

Read More

Insurers say most Obamacare enrollees paying premiums

Three large health insurers including Indianapolis-based WellPoint Inc. and Aetna Inc. say that a high percentage of their new Obamacare customers are paying their first premiums, partly undermining a Republican criticism of enrollment in the program.

Read More

Drug prices surge as generics, niche treatments eat profit

Since 2007, the cost of brand-name medicines has jumped, with prices doubling for dozens of established drugs that target everything from multiple sclerosis to cancer, blood pressure and even erections, according to an analysis conducted for Bloomberg News.

Read More